ASP ISOTOPES INC. COMMON STOCK

NASDAQ: ASPI (ASP Isotopes Inc.)

Last update: 04 Jun, 9:02AM

7.95

0.02 (0.25%)

Previous Close 7.93
Open 8.00
Volume 304,908
Avg. Volume (3M) 2,507,336
Market Cap 666,809,408
Price / Earnings (Forward) 54.35
Price / Sales 109.46
Price / Book 15.37
52 Weeks Range
1.86 (-76%) — 9.33 (17%)
Earnings Date 18 Aug 2025 - 22 Aug 2025
Operating Margin (TTM) -721.89%
Diluted EPS (TTM) -0.590
Quarterly Revenue Growth (YOY) 31.10%
Total Debt/Equity (MRQ) 84.08%
Current Ratio (MRQ) 7.21
Operating Cash Flow (TTM) -16.89 M
Levered Free Cash Flow (TTM) -20.01 M
Return on Assets (TTM) -26.14%
Return on Equity (TTM) -115.46%

Market Trend

Short Term Medium Term
Industry Chemicals (US) Bearish Bearish
Chemicals (Global) Bearish Bearish
Stock ASP Isotopes Inc. Bullish Bullish

AIStockmoo Score

0.8
Analyst Consensus 1.5
Insider Activity NA
Price Volatility -0.5
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 0.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ASPI 667 M - - 15.37
MEOH 2 B 2.30% 10.50 1.01
GPRE 277 M - - 0.470
ORGN 64 M - - 0.210
GURE 8 M - - 0.070
DOW 20 B 5.05% 69.35 1.17

ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.

Sector Basic Materials
Industry Chemicals
Investment Style Small Growth
% Held by Insiders 27.06%
% Held by Institutions 43.83%

Ownership

Name Date Shares Held
Rovida Investment Management Ltd 31 Mar 2025 350,000
52 Weeks Range
1.86 (-76%) — 9.33 (17%)
Median 11.00 (38.37%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
Canaccord Genuity 21 May 2025 11.00 (38.36%) Buy 7.76

No data within this time range.

Date Type Details
11 Jun 2025 Announcement ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE
04 Jun 2025 Announcement ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025
04 Jun 2025 Announcement ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
02 Jun 2025 Announcement ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock
02 Jun 2025 Announcement ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
29 May 2025 Announcement ASP Isotopes Issues Letter to Shareholders
20 May 2025 Announcement ASP Isotopes Inc. Announces an Agreement Relating to the Potential Acquisition of Renergen Limited Expected to Create a Global Critical Materials Company
19 May 2025 Announcement ASP Isotopes Inc. to Host Investor Webcast on Tuesday, May 20, 2025 at 8:00 a.m. EST
19 May 2025 Announcement ASP Isotopes Inc. enters into Definitive Agreements with TerraPower including Loan Agreement for Construction of a HALEU Production Facility and Supply Agreements for HALEU
24 Apr 2025 Announcement ASP Isotopes Inc. Announces Proposed Secondary Listing on the Johannesburg Stock Exchange
17 Apr 2025 Announcement ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
15 Apr 2025 Announcement ASP Isotopes Inc. Announces Changes in Boards of ASP Isotopes Inc. and Quantum Leap Energy LLC
01 Apr 2025 Announcement ASP Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria